DOCTOR FUNGUS
CME program -
"Fungal Infections in Solid Organ Transplant Recipients"

 
Faculty Disclosure

1=Grant/research support | 2=Consultant
3=Speaker's bureau | 4=Stock shareholder
5=Other support

Carol A. Kauffman, MD
  • Enzon Pharmaceuticals, Inc.3
  • Merck & Co, Inc.1
  • Pfizer, Inc.3
  • Versicor, Inc.1


Jay A. Fishman, MD
  • Roche1


Bernard Kubak, MD
  • Enzon Pharmaceuticals, Inc.1.3
  • Pfizer, Inc.3
  • Roche1


Thomas F. Patterson, MD, FACP
  • Affinium Pharmaceuticals, Inc.2
  • Basilea Pharmaceutica2
  • Bristol-Myers Squibb Company1,2
  • Eisai Co., Ltd.2
  • Enzon Pharmaceuticals, Inc.1
  • J. Uriach & Cia. S.A.2
  • Merck & Co., Inc.1,2,3
  • Microbia Inc.2
  • Pfizer, Inc.1,2,3
  • Rib-X Pharmaceuticals, Inc.2
  • Schering-Plough Corporation1,2
  • Vicuron Pharmaceuticals, Inc.2



John R. Perfect, MD
  • Enzon Pharmaceuticals, Inc.1,2,3
  • Merck & Co., Inc. 1,2,3
  • Pfizer, Inc. 1
  • Schering-Plough Corporation1,2,3


The following speakers have disclosed affiliations or financial interests with this educational activity's financial supporter, Fujisawa Healthcare, Inc.:

  • Carol A. Kauffman, MD1,2

  • Jay A. Fishman, MD1

  • Thomas F. Patterson, MD, FACP2,3

  • John R. Perfect, MD1





    		•
    Close this window